Journal
VACCINES
Volume 6, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/vaccines6030048
Keywords
Listeria; cancer; vaccine; immunotherapy; bacteria
Categories
Funding
- Department of Defense Congressionally Directed Medical Research Programs [W81XWH-17-1-0299]
Ask authors/readers for more resources
Listeria monocytogenes, a Gram-positive facultative anaerobic bacterium, is becoming a popular vector for cancer immunotherapy. Indeed, multiple vaccines have been developed utilizing modified Listeria as a tool for generating immune responses against a variety of cancers. Moreover, over a dozen clinical trials testing Listeria cancer vaccines are currently underway, which will help to understand the utility of Listeria vaccines in cancer immunotherapy. This review aims to summarize current views on how Listeria-based vaccines induce potent antitumor immunity and the current state of Listeria-based cancer vaccines in clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available